⌘K

Login Start Free

Home/Filings/4/0001209191-21-024248

4//SEC Filing

Jeffries Sean 4

Accession 0001209191-21-024248

CIK 0001807120other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 6:35 PM ET

Size

4.8 KB

Accession

0001209191-21-024248

Insider Transaction Report

Form 4

Period: 2021-03-30

Design Therapeutics, Inc.DSGN

Chief Operating Officer

Transactions

Purchase
Common Stock
2021-03-30$20.00/sh+3,050$61,000→ 3,050 total(indirect: By domestic partner)

Footnotes (1)

[F1]The shares were purchased in the Issuer's initial public offering.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Design Therapeutics, Inc.

CIK 0001807120

Entity typeother

Related Parties

1

filerCIK 0001848377

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 6:35 PM ET
Size: 4.8 KB

View on SEC.gov